Huntington's Disease: Prevalence and Psychological Indicators of Pain
- PMID: 30363479
- PMCID: PMC6174505
- DOI: 10.1002/mdc3.12376
Huntington's Disease: Prevalence and Psychological Indicators of Pain
Abstract
Background: Huntington's disease (HD) is a genetic neurodegenerative condition that involves impairments in movement, cognition, and mood. Research is lacking in HD with regard to the prevalence of pain and the relationships between psychological factors and pain. The aim of this research was to investigate the prevalence of pain and identify the psychological factors associated with pain severity in people with HD.
Methods: This data-mining study used data from 1474 people who participated in the European Huntington's Disease Network (EHDN) REGISTRY study. Pain severity was measured using the Medical Outcome Study 36-item short-form health survey. Separate ordinal regression analyses were conducted with participant-rated and interviewer-rated psychological measures (the Hospital Anxiety and Depression Scale-Snaith Irritability Scale and the Unified Huntington's Disease Rating Scale). The psychological factors considered were anxiety, depression, irritability, aggression, low self-esteem, and apathy.
Results: The prevalence of pain in the total sample was 41% (stage I, 42%; stage II, 44%; stage III, 39%; stages IV and V, 50%). After controlling for confounding variables, pain severity was significantly associated with participant-rated anxiety and depression. Interviewer-rated anxiety, depression, and irritability also were significantly associated with severity of pain after controlling for confounding variables.
Conclusions: This research confirmed that pain is indeed an issue for people with HD, particularly during the later stages of the disease. Caregivers and health professionals should consider the possibility that people with HD might be experiencing pain, particularly if they are showing signs of anxiety, depression, or irritability.
Keywords: Huntington's disease; anxiety; depression; irritability; pain.
Figures
Similar articles
-
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1411-8. doi: 10.1136/jnnp-2013-307343. Epub 2014 May 14. J Neurol Neurosurg Psychiatry. 2014. PMID: 24828898
-
Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington's disease gene expansion carriers.J Affect Disord. 2018 Mar 1;228:194-204. doi: 10.1016/j.jad.2017.11.074. Epub 2017 Nov 15. J Affect Disord. 2018. PMID: 29253686
-
Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease.Neurol Sci. 2022 Oct;43(10):6079-6085. doi: 10.1007/s10072-022-06226-1. Epub 2022 Jun 21. Neurol Sci. 2022. PMID: 35725858
-
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.Mov Disord. 2016 Oct;31(10):1466-1478. doi: 10.1002/mds.26675. Mov Disord. 2016. PMID: 27296904 Review.
-
Validity of irritability in Huntington's disease: A scoping review.Cortex. 2019 Nov;120:353-374. doi: 10.1016/j.cortex.2019.06.012. Epub 2019 Jul 8. Cortex. 2019. PMID: 31401402
Cited by
-
"I Wouldn't Even Know What to Ask for": Patients' and Caregivers' Experiences of Psychological Support for Huntington's Disease in Italy.NeuroSci. 2024 Mar 28;5(2):98-113. doi: 10.3390/neurosci5020007. eCollection 2024 Jun. NeuroSci. 2024. PMID: 39483497 Free PMC article.
-
Psychological Interventions for People with Huntington's Disease: A Call to Arms.J Huntingtons Dis. 2020;9(3):231-243. doi: 10.3233/JHD-200418. J Huntingtons Dis. 2020. PMID: 32894248 Free PMC article.
-
Guided self-help for anxiety among Huntington's disease gene expansion carriers (GUIDE-HD) compared to treatment as usual: a randomised controlled feasibility trial.Pilot Feasibility Stud. 2023 Sep 12;9(1):159. doi: 10.1186/s40814-023-01364-5. Pilot Feasibility Stud. 2023. PMID: 37700320 Free PMC article.
-
Pain in Huntington's disease and its potential mechanisms.Front Aging Neurosci. 2023 Jul 6;15:1190563. doi: 10.3389/fnagi.2023.1190563. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37484692 Free PMC article. Review.
-
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated.Antioxidants (Basel). 2022 Jul 4;11(7):1321. doi: 10.3390/antiox11071321. Antioxidants (Basel). 2022. PMID: 35883812 Free PMC article.
References
-
- Novak MJ, Tabrizi SJ. Huntington's disease [serial online]. BMJ 2010;340:c3109. - PubMed
-
- Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington disease. Cogn Behav Neurol 2001;14:219–226. - PubMed
-
- Van Duijn E, Kingma E, Van der Mast R. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007;19:441–448. - PubMed
-
- Calvert M, Pall H, Hoppitt T, Eaton B, Savill E, Sackley C. Health‐related quality of life and supportive care in patients with rare long‐term neurological conditions. Qual Life Res 2013;22:1231–1238. - PubMed
LinkOut - more resources
Full Text Sources